Jan 2023: Patent Reform And Lower Drug Prices Should Be Bipartisan Priorities

29 Jan 2023

Hello everyone,

I’m excited to share a new opinion piece that my co-ED Priti Krishtel and I published yesterday in The Hill explaining the unique and important bipartisan appeal of fixing the broken drug patent system.
READ: Patent Reform And Lower Drug Prices Should Be Bipartisan Priorities 

Stopping the corporate gamesmanship that has distorted our patent system is not a partisan issue; it’s an American issue. The new Congress has an opportunity to address it, once and for all.

Wishing you a peaceful start to 2023,
Tahir

Partner with us now to build
a more just and equitable
medicine system for all.